Updated:
CaraMed Capital
CaraMed Capital is a New Zealand-based healthcare venture capital fund founded in 2020 and headquartered in Auckland. The firm operates as an institutional...
Overview
CaraMed Capital is a New Zealand-based healthcare venture capital fund founded in 2020 and headquartered in Auckland. The firm operates as an institutional investor with $50 million in assets under management. CaraMed Capital focuses on investing in healthtech companies located in New Zealand. The firm's portfolio includes one known investment in Xylo Bio, made as part of their Seed VC - II fund on October 27, 2022. As a specialized healthcare VC, CaraMed Capital targets seed-stage opportunities within the health technology sector, supporting the growth of innovative healthtech ventures in the New Zealand market.
General information
Firm type
Institutional Investor
AUM
$50 million
Location
Country
New Zealand
City
Auckland
Corporate office
Auckland, New Zealand
Sector focus
Frequently asked questions
What is CaraMed Capital's investment focus?
CaraMed Capital focuses on investing in healthtech companies based in New Zealand, targeting seed-stage opportunities within the healthcare technology sector.
How much does CaraMed Capital have in assets under management?
CaraMed Capital has $50 million in assets under management.
Where is CaraMed Capital headquartered?
CaraMed Capital is headquartered in Auckland, New Zealand.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: